OBJECTIVE: To evaluate visual field deterioration in patients with glaucoma with and without optic disc hemorrhages (DHs). DESIGN: A prospective study at quarterly base involving annual perimetry; mean follow-up of 9 years. SETTING: Outpatient department, nonreferral basis. PATIENTS: Sixty-eight patients with primary open-angle glaucoma, 34 with normal pressure glaucoma (NPG), and 125 with ocular hypertension. RESULTS: Visual field deterioration occurred in 32%, 32%, and 6% of the patients without DHs who had NPG, primary open-angle glaucoma, or ocular hypertension, respectively, while visual field deterioration occurred in 80%, 89%, and 14% of patients with DH, respectively. Cox proportional hazards ratio(CHR) for deterioration in patients with vs patients without DHs was 5.4 for NPG (P<.01) and 3.6 for primary open-angle glaucoma (P<.01). In patients with NPG and DHs, ipsilateral eyes with DHs deteriorated in 58%, while contralateral eyes without DHs deteriorated in 11% (CHR, 8.9; P<.04). For primary open-angle glaucoma and ocular hypertension, progression did not differ between eyes with DHs and contralateral eyes without DHs. Mean (+/-SD) interval between DHs and ipsilateral visual field deterioration was 3.1+/-1.7 years. No difference in the proportion of eyes progressing after single or recurrent DHs was noted. The position of DHs was related to the site of the visual field loss in 44% of the eyes. CONCLUSIONS: The presence of DHs increased the risk of visual field deterioration. Disc hemorrhages were indicative only of deterioration in ipsilateral eyes in patients with NPG.
OBJECTIVE: To evaluate visual field deterioration in patients with glaucoma with and without optic disc hemorrhages (DHs). DESIGN: A prospective study at quarterly base involving annual perimetry; mean follow-up of 9 years. SETTING:Outpatient department, nonreferral basis. PATIENTS: Sixty-eight patients with primary open-angle glaucoma, 34 with normal pressure glaucoma (NPG), and 125 with ocular hypertension. RESULTS:Visual field deterioration occurred in 32%, 32%, and 6% of the patients without DHs who had NPG, primary open-angle glaucoma, or ocular hypertension, respectively, while visual field deterioration occurred in 80%, 89%, and 14% of patients with DH, respectively. Cox proportional hazards ratio(CHR) for deterioration in patients with vs patients without DHs was 5.4 for NPG (P<.01) and 3.6 for primary open-angle glaucoma (P<.01). In patients with NPG and DHs, ipsilateral eyes with DHs deteriorated in 58%, while contralateral eyes without DHs deteriorated in 11% (CHR, 8.9; P<.04). For primary open-angle glaucoma and ocular hypertension, progression did not differ between eyes with DHs and contralateral eyes without DHs. Mean (+/-SD) interval between DHs and ipsilateral visual field deterioration was 3.1+/-1.7 years. No difference in the proportion of eyes progressing after single or recurrent DHs was noted. The position of DHs was related to the site of the visual field loss in 44% of the eyes. CONCLUSIONS: The presence of DHs increased the risk of visual field deterioration. Disc hemorrhages were indicative only of deterioration in ipsilateral eyes in patients with NPG.
Authors: Donald L Budenz; Julia Beiser Huecker; Steven J Gedde; Mae Gordon; Michael Kass Journal: Am J Ophthalmol Date: 2016-11-07 Impact factor: 5.258
Authors: Huiyuan Hou; Sasan Moghimi; Linda M Zangwill; James A Proudfoot; Tadamichi Akagi; Takuhei Shoji; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Ophthalmol Glaucoma Date: 2019-11-14
Authors: Tadamichi Akagi; Linda M Zangwill; Luke J Saunders; Adeleh Yarmohammadi; Patricia Isabel C Manalastas; Min Hee Suh; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Ophthalmology Date: 2017-05-09 Impact factor: 12.079
Authors: Heather C de Beaufort; Carlos Gustavo V De Moraes; Christopher C Teng; Tiago S Prata; Celso Tello; Robert Ritch; Jeffrey M Liebmann Journal: Graefes Arch Clin Exp Ophthalmol Date: 2010-02-25 Impact factor: 3.117
Authors: Sally L Baxter; Charles Marks; Tsung-Ting Kuo; Lucila Ohno-Machado; Robert N Weinreb Journal: Am J Ophthalmol Date: 2019-07-16 Impact factor: 5.258
Authors: Daiyan Xin; Vivienne C Greenstein; Robert Ritch; Jeffrey M Liebmann; Carlos Gustavo De Moraes; Donald C Hood Journal: Invest Ophthalmol Vis Sci Date: 2011-01-25 Impact factor: 4.799
Authors: Xinbo Zhang; Anna Dastiridou; Brian A Francis; Ou Tan; Rohit Varma; David S Greenfield; Joel S Schuman; Mitra Sehi; Vikas Chopra; David Huang Journal: Am J Ophthalmol Date: 2016-09-17 Impact factor: 5.258
Authors: Alon Skaat; Carlos Gustavo De Moraes; Christopher Bowd; Pamela A Sample; Christopher A Girkin; Felipe A Medeiros; Robert Ritch; Robert N Weinreb; Linda M Zangwill; Jeffrey M Liebmann Journal: Ophthalmology Date: 2016-04-23 Impact factor: 12.079